Brian Law^1*, Tripta Rughwani, MS^1*, Tenley C. Archer, PhD^1*, Lekha Kumar, MS^1*, Daniel Lu, MS^1*, Priyanka Somanath, PhD^2*, Yan Ma, PhD^2*, Xiaodong Wang, MS^1*, David Sperandio, PhD^1*, Steve Morris^2*, Thorsten Kirschberg, PhD^1*, Mini Balakrishnan, PhD^1* and Thomas Butler, MSc, MBA^1,2*

¹Biomea Fusion Inc., San Carlos, CA
²Biomea Fusion Inc., Redwood City, CA

Jorge E. Cortes, MD¹, Pierre Fenaux², Karen Yee, MD³, Christian Recher, MD⁴, Andrew H. Wei, MBBS, FRACP, FRCPA, PhD⁵, Pau Montesinos, PhD, MD^6*, David C Taussig, PhD, FRCPath, MRCP⁷, Arnaud Pigneux, MD, PhD^8*, Thorsten Braun, MD, PhD⁹, Antonio Curti, MD, PhD¹⁰, Carolyn Grove, MBBS, PhD^11*, Brian A. Jonas, MD, PhD¹², Asim Khwaja, MD, FRCP, FRCPath^13*, Pierre Peterlin, MD^14*, Olga Polyanskaya, MS^15*, Jennifer Sweeney^15*, Julie Brevard, MPH^15*, Emma Barrett, MD^15* and Stephane De Botton, MD, PhD^16*

¹Georgia Cancer Center, Augusta, GA
²Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France
³Princess Margaret Cancer Centre, Toronto, ON, Canada
⁴Institut Universitaire du Cancer de Toulouse Oncopole, CHU de Toulouse, Toulouse, France
⁵The Alfred Hospital and Monash University, Melbourne, VIC, Australia
⁶Hospital Universitari i Politècnic La Fe, Valencia, Spain
⁷The Royal Marsden NHS Foundation Trust, New Malden, United Kingdom
⁸Hématologie Clinique et Thérapie cellulaire, CHU Bordeaux, Bordeaux, France
⁹Clinical Hematology, Avicenne Hospital, APHP, University Paris XIII, Bobigny, France
¹⁰IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Seragnoli, Bologna, Italy
¹¹Department of Haematology, Sir Charles Gairdner Hospital & PathWest, Nedlands, Australia
¹²Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA
¹³Cancer Institute, University College London, London, United Kingdom
¹⁴Nantes University Hospital, Nantes, France
¹⁵Forma Therapeutics, Inc., Watertown, MA
¹⁶Department of Haematology, Institut Gustave Roussy, Villejuif, France

Naval Daver, MD¹, Kyoo Hyung Lee, MD, PhD^2*, Brian A. Jonas, MD, PhD³, Martha L. Arellano, MD⁴, Chul W. Jung, MD, PhD⁵, Sang Kyun Sohn^6*, Sung-Soo Yoon, MD, PhD⁷, Jeong-Ok Lee, MD Ph.D.⁸, Jia Hu, PhD^9*, Ranjeet Kumar Sinha, PhD^9*, William G Rice, PhD¹⁰ and Rafael Bejar, MD, PhD^10,11

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
³Department of Internal Medicine, Division of Malignant Hematology, Transplantation and Cellular Therapy, University of California Davis School of Medicine, Sacramento, CA
⁴Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
⁵Samsung Medical Center, Seoul, KOR
⁶Kyungpook National University Hospital, Daegu, Korea, Republic of (South)
⁷Division of Hematology/Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁸Division of Hemato-Oncology, Department of Internal medicine, Seoul National University Bundang Hospital, Seongnam, None, Korea, Republic of (South)
⁹Aptose Bioscience Inc, San Diego, CA
¹⁰Aptose Biosciences, Inc., San Diego, CA
¹¹Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA

Uma Borate, MD¹, Rui Li, MPH^1*, Ying Huang, MS, MA^2*, Ronan T. Swords, MD^3*, Elie Traer, MD, PhD⁴, Eytan Stein, MD⁵, James M. Foran, MD⁶, Maria R. Baer, MD⁷, Vu H. Duong, MD, MS⁷, Wendy Stock, MD⁸, Olatoyosi Odenike, MD⁹, Prapti Patel, MD¹⁰, Robert H. Collins, M.D.¹¹, Yazan F. Madanat, MD¹¹, Tibor Kovacsovics, MD¹², Michael W. Deininger, MD, PhD¹³, Catherine Smith, MD¹⁴, Rebecca L. Olin, MD¹⁵, Martha L. Arellano, MD¹⁶, William G. Blum, MD¹⁷, Gary J. Schiller, MD¹⁸, Tara L. Lin, MD¹⁹, Matthew C. Foster, MD²⁰, Michael M. Boyiadzis, MD²¹, Robert L. Redner, MD²², Zeina Al-Mansour, MD^23*, Emily K Curran, MD^24,25, Nyla A. Heerema, PhD²⁶, Theophilus J Gana, MD PhD^27*, Molly Martycz^28*, Leonard Rosenberg, PhD RPh^29*, Sonja Marcus, MPH^30*, Ashley O. Yocum, PhD^31*, Timothy Chen, PhD^32*, Mona Stefanos^28*, Franchesca Druggan, MSc^33*, Amy Burd, PhD³⁴, Ross L. Levine, MD³⁵, Brian J. Druker³⁶, John C. Byrd, MD³⁷ and Alice S. Mims, MD²

¹Division of Hematology, The Ohio State University, Columbus, OH
²Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
³Knight Cancer Institute/ Division of Hematology/Medical Oncology, Oregon Health & Science University, Portland, OR
⁴Knight Cancer Institute, Division of Hematology & Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, OR
⁵Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Division of Hematology/Oncology and Blood and Marrow Transplanation and Cellular Therapy, Mayo Clinic, Jacksonville, FL
⁷University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
⁸University of Chicago, Chicago, IL
⁹Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
¹⁰Division of Hematology and Oncology, University of Texas Southwestern, Dallas, TX
¹¹Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
¹²Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
¹³Division of Hematology and Hematologic Malignancies, The University of Utah, Huntsman Cancer Institute, Salt Lake City, UT
¹⁴Division of Hematology and Blood and Marrow Transplantation, University of California, San Francisco, San Francisco, CA
¹⁵University of California, San Francisco, San Francisco, CA
¹⁶Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
¹⁷Department of Hematology and Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
¹⁸David Geffen School of Medicine at UCLA, Los Angeles, CA
¹⁹University of Kansas, Westwood, KS
²⁰Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
²¹Univ. of Pittsburgh Cancer Inst., Pittsburgh, PA
²²UPMC Hillman Cancer Center, Pittsburgh, PA
²³UF Health Shands Hospital, University of Florida, Gainesville, FL
²⁴Department of Medicine, Section of Hematology/Oncology, University of Chicago, Cincinnati, OH
²⁵University of Cincinnati, Cincinnati, OH
²⁶Department of Pathology, The Ohio State University, Columbus, OH
²⁷Biopharmatech Consulting, Inc., Leesburg, VA
²⁸The Ohio State University Comprehensive Cancer Center, Columbus, OH
²⁹Leukemia & Lymphoma Society, Mount Laurel, NJ
³⁰Leukemia & Lymphoma Society, Rye Brook, NY
³¹The Leukemia & Lymphoma Society, Rye Brook, NY
³²Department of Internal Medicine, Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH
³³The Ohio State University, Columbus, OH
³⁴The Leukemia & Lymphoma Society, White Plains, NY
³⁵Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
³⁶Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR
³⁷University of Cincinnati College of Medicine, Cincinnati, OH

Justin Watts, MD¹, Michael Maris, MD², Tara L. Lin, MD³, Prapti Patel, MD^4*, Yazan F. Madanat, MD⁵, Christopher R. Cogle, MD⁶, Gautam Borthakur, MD⁷, Dirk Huebner, MD^8*, Noor Khaskhely, MD^8*, Lynn Bonham, PhD^8*, Monica Massaro, MPH^8*, Daphne Taylor, CPA^8*, Caroline Taromino, MBA^8* and Alice S. Mims, MD⁹

¹Sylvester Comprehensive Cancer Center, University of Miami, Coral Gables, FL
²Sara Cannon Research Institute, Denver, CO
³University of Kansas, Westwood, KS
⁴Servier Pharmaceuticals, Boston
⁵Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
⁶Department of Medicine, University of Florida, Gainesville, FL
⁷Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Aptevo Theraputics, Seattle, WA
⁹Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH

Faustine Ong, MD^1*, Guillermo Garcia-Manero, MD², Guillermo Montalban-Bravo, MD³, Yesid Alvarado, MD³, Maro Ohanian, DO^3*, Marina Konopleva, MD, PhD⁴, Elias Jabbour, MD³, Nitin Jain, MD⁵, Gautam Borthakur, MD³, Courtney D. DiNardo, MD, MSCE³, Naval Daver, MD³, Ghayas C. Issa, MD⁶, Koji Sasaki, MD³, Kelly S. Chien, MD³, Koichi Takahashi, MD, PhD⁷, Michael Andreeff, MD, PhD³, Muharrem Muftuoglu, MD³, Ricardo Delumpa, BSN^3*, Ejiroghene Mayor, BSN, RN^3*, Christopher Loiselle, BS^3*, Lourdes Waller^3*, Glenda Banks^3*, Hagop Kantarjian, MD⁸, Jorge E. Cortes, MD⁹ and Nicholas Short, MD⁷

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, HOUSTON, CA
²Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Albert Einstein College of Medicine, Bronx, NY
⁵Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁶Department of Leukemia, Universit Y of Texas At Houston, Houston, TX
⁷Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁸Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Georgia Cancer Center, Augusta, GA

Adam J. Lamble, MD¹, Xiaowei Liu, MS^2*, Charles Minard, PhD^3*, Olga Militano, PharmD^2*, Melanie Brooke Bernhardt, PharmD^4*, Todd M. Cooper, DO¹, Edward A. Kolb, MD⁵, Erin H. Breese, MD, PhD⁶, Elizabeth Fox, MD^7*, Sarah K Tasian, MD⁸ and Brenda J. Weigel, MD, MSc^9*

¹Seattle Children's Hospital, Seattle, WA
²Children's Oncology Group, Monrovia, CA
³Dan L. Duncan Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX
⁴Texas Children's Hospital, Baylor College of Medicine, Department of Pediatrics, Hematology/Oncology Section, Houston, TX
⁵Division of Oncology, Nemours Alfed I. duPont Hospital For Children, Wilmington, DE
⁶Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
⁷St. Jude Children's Research Hospital, Memphis, TN
⁸Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
⁹University of Minnesota, Minneapolis, MN

Hisayuki Yokoyama, MD, PhD¹, Koji Ando, MD, PhD², Noriko Fukuhara, MD, PhD^3,4, Hiroatsu Iida, MD, PhD^5*, Suguru Fukuhara, MD^6*, Hiroshi Miyake, PhD^7*, Yasushi Tanoue^8*, Maki Yamamoto, MS^9*, Hirokazu Tozaki, PhD^10*, Akio Mizutani, PhD^10*, Daisuke Morishita, PhD^10*, Kunihiko Takeyama, MD, PhD¹¹, Toshio Shimizu, MD, PhD^12* and Noboru Yamamoto, MD, PhD^13*

¹Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan
²Nagasaki University, Atomic Bomb Disease Institute, Nagasaki, Japan
³Department of Hematology, Tohoku University School of Medicine, Sendai, Japan
⁴Department of Hematology, Tohoku University Hospital, Sendai, Japan
⁵Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
⁶Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
⁷Chordia Therapeutics Inc., Fujisawa, Japan
⁸Chordia Therapeutics Inc., Chuo-Ku, Japan
⁹Chordia Therapeutics Inc., Tokyo, JPN
¹⁰Chordia Therapeutics Inc., Fujisawa, Kanagawa, Japan
¹¹Tokyo Medical University, Tokyo, JPN
¹²Department of Medical Oncology, Wakayama Medical University Hospital, Wakayama, Japan
¹³Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, TKY, JPN

Brian A. Jonas, MD, PhD¹, Jeanna L Welborn, MD², Naseem S Esteghamat, MD³, Rasmus T Hoeg, MD^3*, Aaron S Rosenberg, MD³, Laura Molnar, CCRP^4*, Ashley Linh Dang-Chu, CCRP^4*, Susan L Stewart, PhD^5* and Joseph M Tuscano, MD³

¹Department of Internal Medicine, Division of Malignant Hematology, Transplantation and Cellular Therapy, University of California Davis School of Medicine, Sacramento, CA
²Department of Internal Medicine, Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA
³Department of Internal Medicine, Division of Cellular Therapy, Bone Marrow Transplantation and Malignant Hematology, University of California Davis School of Medicine, Sacramento, CA
⁴UC Davis Comprehensive Cancer Center, Sacramento, CA
⁵Division of Biostatistics, University of California Davis, Sacramento, CA

Florent Malard, MD, PhD^1*, Sylvain Thepot^2*, Thomas Cluzeau, MD, PhD³, Martin Carre, MD^4*, Delphine Lebon, MD^5*, Cyrielle Gasc, PhD^6*, Juliette Jouve^6*, Benoit Levast, PhD^7*, Emilie Plantamura, PhD, PharmD^6*, Emmanuel Prestat, PhD^6*, Antoine Sabourin^6*, Joel Doré, PhD^8*, Mohamad Mohty, MD PhD⁹ and Christian Recher, MD¹⁰

¹Department of Clinical Hematology and Cellular Therapy, Sorbonne University, Saint Antoine Hospital, Assistance Publique - Hôpitaux de Paris, INSERM UMRs 938, Centre de Recherche Saint-Antoine (CRSA), Paris, France
²Clinical Hematology, Angers University Hospital, Angers, France
³Hematology department, Cote D'Azur University, CHU of Nice, Nice, France
⁴Hematology, CHU Grenoble Alpes, La Tronche, France
⁵Service d’Hématologie, Centre Hospitalier Universitaire Amiens – Picardie, Amiens, France
⁶MaaT Pharma, Lyon, France
⁷MaaT pharma, Lyon, France
⁸Université Paris-Saclay,, INRAE, Metagenopolis, Jouy-en-Josas, France
⁹EBMT Paris study office / CEREST-TC, Paris, France, Department of Hematology, Saint Antoine Hospital, Paris, France, INSERM UMR 938, Sorbonne University, Paris, France
¹⁰Service d'Hématologie, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France

David Levitz, MD¹, Kateryna Fedorov, MD¹, Kith Pradhan, PhD^2*, Lauren C Shapiro, MD¹, Aditi Shastri, MD³, Kira Gritsman, MD, PhD¹, Nishi Shah, MD, MPH¹, Noah Kornblum, MD^4*, R. Alejandro Sica, MD¹, Ira Braunschweig, MD¹, Marina Konopleva, MD^1*, Eric J. Feldman, MD^1*, Amit Verma, MD¹, Ioannis Mantzaris, MD¹, Yogenthiran Saunthararajah, MD⁵ and Mendel Goldfinger, MD¹

¹Hematology/Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
²Department of Epidemiology & Population Health, Montefiore Medical Center, Bronx, NY
³Oncology, Hematology/Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
⁴Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
⁵Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Aaron D Goldberg, MD, PhD¹, Maro Ohanian, DO^2*, Paul B. Koller, MD³, Mohamad Cherry, MD, MS⁴, Jessica K. Altman, MD⁵, Benjamin Tomlinson, MD⁶, Namrata Sonia Chandhok, MD⁷, Donna Nguyen Haney^8*, Jia Hu, PhD^9*, Ranjeet Kumar Sinha, PhD^9*, William G Rice, PhD¹⁰ and Rafael Bejar, MD, PhD^10,11

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
⁴Hematology and Medical Oncology, Morristown Medical Center, Morristown, NJ
⁵Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
⁶Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH
⁷University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
⁸Aptose Bioscience Inc, San Diego
⁹Aptose Bioscience Inc, San Diego, CA
¹⁰Aptose Biosciences, Inc., San Diego, CA
¹¹Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA

David Taussig, PhD, MRCP, FRCPath¹, Jenny O'Nions^2*, Mojca Jongen-Lavrencic³, Jeroen J. Janssen, MD, PhD⁴, David C. de Leeuw, MD, PhD^5*, Peter T. Tan, MBBS^6*, Sue Brook, MD^7*, Katie Stoddart, BSc^7*, Hendrik-Tobias Arkenau, MD PhD^7* and Geoff Fisher, PhD^7*

¹Haematology, Royal Marsden Hospital, London, United Kingdom
²University College London Hospital NHS Foundation Trust, London, United Kingdom
³Erasmus Medical Centre, Rotterdam, Netherlands
⁴Amsterdam UMC, Hilversum, Netherlands
⁵Department of Hematology, Amsterdam University Medical Center, location VUMC, Amsterdam, Netherlands
⁶Royal Perth Hospital, Perth, Australia
⁷Ellipses Pharma, London, United Kingdom

Xining Yang, PhD¹, Kathrin Krowiorz, PhD^2*, Raj Bhayadia, PhD^3*, Jessica Kohlschmidt, PhD⁴, Deedra Nicolet, MS⁴, Tobias Maetzig, PhD^5*, Caroline Pabst, MD^6*, Jeremy Hui, BS^7*, Arshia Shad, BS^7*, Sharon Gao^7*, Maria Stephenson^7*, Si Wei Wu, BS^7*, Marion van den Bosch, PhD^8*, Daelynn Buelow, PhD^9*, Sharyn Baker, PharmD PhD⁹, Leo Escano, BS^7*, Frances E Lock, PhD^1*, Afsaneh Panahi, MS⁷, Liam MacPhee, BS⁷, Irina Maksakova, PhD^7*, Amanda Amoah, PhD^7*, Konstanze Döhner, MD², Linda Fogelstrand, MD PhD¹⁰, Ann-Kathrin Eisfeld, MD¹¹, Sanaz Yahyanejad, PhD^8*, Michel Janicot, PhD^8*, Christopher C. Oakes, PhD⁴, Jan-Henning Klusmann, MD³, Arefeh Rouhi, PhD^7* and Florian Kuchenbauer, MD PhD¹

¹Terry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, BC, Canada
²Division of Hematology and Oncology, University Hospital Ulm, Ulm, Germany
³Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany
⁴Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus
⁵Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany
⁶Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
⁷Terry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, Canada
⁸InteRNA Technologies BV, Utrecht, Netherlands
⁹Division of Pharmaceutics and Pharmacology, College of Pharmacy, Comprehensive Cancer Center, The Ohio State University, Columbus
¹⁰Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden
¹¹Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University, Columbus, OH

Johanna Rausch, MD^1*, Margarita M. Dzama, PhD^1*, Nadezda Dolgikh, PhD^1*, Hanna Stiller^1*, Stephan Bohl, MD^2*, Catharina Lahrmann^1*, Kerstin Kunz^1*, Linda Kessler, BA^3*, Hakim Echchannaoui, PhD^1*, Chun-Wei David Chen, PhD⁴, Thomas Kindler, MD^5*, Francis Burrows, PhD^3*, Matthias Theobald, MD^1*, Daniel Sasca, MD^1*, Scott A. Armstrong, MD, PhD^6,7 and Michael Kuehn, MD^1*

¹Department of Hematology, Medical Oncology, and Pulmonary Medicine, University Medical Center, Johannes Gutenberg-University, Mainz, Germany
²DFCI, Boston
³Kura Oncology, San Diego, CA
⁴Department of Systems Biology, Beckman Research Institute, Duarte, CA
⁵University Cancer Center of Mainz, Mainz, Germany
⁶Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA
⁷Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA

Camille Abboud Sr., MD¹, Jan Maciej Zaucha, MD^2*, Scott R. Solomon, MD³, Terrence Bradley, MD⁴, Elie Mouhayar, MD^5*, Noemi Angelosanto, MD⁶, Hendrik Nogai^6*, Renata Dudziak, MD^7*, Tomasz Rzymski, PhD^6*, Peter Littlewood, BSc^8*, Krzysztof Brzózka, PhD^6*, Axel Glasmacher, MD⁹, Gautam Borthakur, MD¹⁰, Howard A. Burris Sr., MD¹¹ and Ewa Lech Marańda, MD, PhD^12*

¹Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
²Early Phase Clinical Trial Unit, University Clinical Center, Gdansk, Poland
³Leukemia Program, Northside Hospital Cancer Center Institute, Atlanta, GA
⁴University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
⁵MDACC, Houston, TX
⁶Ryvu Therapeutics, Cracow, Poland
⁷Ryvu Therapeutics, Kraków, Poland
⁸Ryvu Therapeutics, Krakow, Poland
⁹Dep. of Internal Medicine III, University Clinic Bonn, Bonn, Germany
¹⁰Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Sarah Cannon Research Institute, Nashville, TN
¹²Institute of Hematology and Transfusion Medicine, Warsaw, Poland

Daria Gaut, MD¹, Caspian Oliai, MD, MS¹, Steven Tsai, MD, PhD¹, Chi-Hong Tseng, PhD^2*, Aaron C. Logan, MD, PhD³ and Gary J. Schiller, MD¹

¹UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA
²Department of Statistics, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, CA
³Division of Hematology and Blood and Marrow Transplantation, University of California, San Francisco, San Francisco, CA

Aditya S Sheth, MSc^1,2*, Ka-Kui Chan, PhD^2*, Grzegorz Nalepa, MD, PhD^1,2,3, D. Wade Clapp, MD^1,2,3 and Elizabeth Sierra Potchanant, PhD^2*

¹Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN
²Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN
³Pediatrics, Riley Hospital for Children, Indianapolis, IN

Vaibhav Agrawal, MD¹, Cindy Croslin, BSN, CRN^1*, Asuscena L. Beltran^1*, Jianying Zhang, PhD^2*, Joycelynne Palmer, PhD^3*, Quy Huynh-Tran^1*, Rochelle Hernandez^1*, Sandra Thomas, PhD^4*, Marjorie Robbins, PhD^4*, Ahmed Aribi, MD^1*, Haris Ali, MD¹, Anthony S. Stein, MD^1*, Elizabeth L. Budde, MD, PhD⁵, Monzr M. Al Malki, MD^1* and Guido Marcucci, MD¹

¹Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
²Department of Computational and Quantitative Medicine-BRI, City of Hope National Medical Center, Duarte, CA
³Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope, Duarte, CA
⁴Department of Clinical and Translational Project Development, City of Hope National Medical Center, Duarte, CA
⁵Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA

Sammicheli Stefano, PhD^1*, Camille Grandclement, PhD^1*, Valentina Labanca^1*, Stefania De Angelis^1*, Carole Estoppey, PhD^2*, Myriam Chimen, PhD^1*, Blandine Pouleau^2*, Perrine Suere^2*, Emilie Nallet^2*, Ankita Srivastava, PhD^2*, Eric J. Feldman, MD^3*, Igor Proscurshim, MD^4*, Cyril Konto, MD⁴, Eugene Zhukovsky, PhD² and Mario Perro, PhD^2*

¹Ichnos Sciences, Epalinges, Switzerland
²Ichnos Sciences Biotherapeutics SA, Lausanne, Switzerland
³Ichnos Sciences, New York
⁴Ichnos Sciences, New York, NY

Michele Mayo, M.S.^1*, Yogesh Chutake, PhD^1*, Rahul Karnik, Ph.D.^1*, Alice McDonald, PhD^1*, Patricia S. Cho, PhD^1*, Jessica Filiatrault, M.S.^1*, Dapeng Chen, PhD^1*, Vaishali Dixit, Ph.D.^1*, William Proctor, PhD^2*, Susanne Breitkopf, PhD^1*, Frank Qi, PhD^1*, Kan-Nian Hu, PhD^1*, Kirti Sharma, Ph.D.^1*, Reggie Ewesuedo, MD^1*, Matt Weiss, PhD^1*, Joseph D. Growney, PhD^1*, Juliet Williams, PhD^1* and Stefanie S Schalm^1*

¹Kymera Therapeutics, Watertown, MA
²200 Arsenal Yards Blvd., Suite 230, Kymera Therapeutics, Watertown, MA